中晚期中央型肺癌介入治疗的临床研究

目的对比分析中晚期中央型肺癌支气管动脉介入治疗与全身静脉化疗的疗效。方法中央型中晚期肺癌85例,均经病理证实,分为支气管动脉介入治疗组与全身静脉化疗组。结果支气管动脉介入治疗组肺内原发病灶、远处转移灶、肺外淋巴结转移灶的有效率分别为59.52%、18.18%、55.56%;全身静脉化疗组分别为30.23%、53.85%、52.63%。肺内原发病灶、远处转移灶两组间有效率的差异有统计学意义(P<0.05)。结论支气管动脉介入治疗比全身静脉化疗能更有效地控制肺内原发病灶,但对远处转移灶治疗控制能力较低。

Clinical study of interventional theraphy in moderate-late central type carcinoma of lung

Objective To compare the therapeutic effectiveness of bronchial arterial infusion(BAI) and traditional vein chemotherapy in moderate-late central type carcinoma of lung.Method Eighty-five patients with moderate-late central type carcinoma of lung were randomly treated by BAI(BAI group) and traditional vein chemotherapy(traditional vein chemotherapy group).Results The response rate of primary lesion,metastasis,transfer of lymph nodes in BAI group were 59.52%,18.18%,55.56%,in traditional vein chemotherapy group were 30.23%,53.85%,52.63%.The response rate of primary lesion,metastasis were different between the two groups(P <0.05).Conclusion BAI is better than traditional vien chemotherapy in effect of lung primary lesion,but is worse than traditional vein chemotherapy in effect of metastasis.